Cardiovascular diseases (CVDs) are associated with high mortality rate all over the world. Strokes and heart attacks are two major types of CVD contributing to the growing mortality rate globally. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease (CHD) is the most common type of CVD resulting in heart attack in the US. In the US, about 370,000 people die due to CHD every year. The EP diagnostics and treatment devices such as ablation catheters, pacemakers, and implantable cardioverter defibrillators (ICDs) are used extensively for the CVD treatment.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Diagnostic EP devices

Treatment EP devices

PART 07: Market segmentation by end-users

Hospitals

Clinics

Diagnostic centers

PART 08: Geographical segmentation

EP devices market in Americas

EP devices market in EMEA

EP devices market in APAC

PART 09: Market drivers

Increasing incidence of arrhythmia cases

Increasing preference for remote monitoring devices

High demand for EP devices

PART 10: Impact of drivers

PART 11: Market challenges

High cost of ablation procedures

Side-effects associated with X-ray systems

Complications associated with ablation procedures

PART 12: Impact of drivers and challenges

PART 13: Market trends

Development of leadless pacemaker

Increased adoption of multi-functional pacemakers

Use of mobile ECG monitoring systems

PART 14: Vendor landscape

Competitive scenario

PART 15: Key vendor analysis

Boston Scientific

GE Healthcare

Medtronic

Philips Healthcare

St. Jude Medical

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: Explore Technavio